首页 > 会议日程详情
2024-11-16 星期六
13:00-14:40 719阿里山

论文交流-35
主持人

杨帆 

南京医科大学第四附属医院

王草叶 

常州市第一人民医院

Prognostic Prediction of Immune Indicator Changing Trend in Unresectable Hepatocellular Carcinoma Undergoing TACE plus ICIs and Anti-VEGF Antibodies/TKIs

徐啸阳  13:00-13:08

苏州大学附属第一医院[论文发言]

Analysis of short-term efficacy of ive genicular artery embolization combined with platelet rich plasma injection in the treatment of knee osteoarthritis

孙向阳  13:10-13:18

山东大学齐鲁医院[论文发言]

Transarterial chemoembolisation and tyrosine kinase inhibitors with or without programmed death-1 inhibitors as first-line treatment for unresectable hepatocellular carcinoma: A propensity score matching study

杨学刚  13:20-13:28

四川省肿瘤医院[论文发言]

COMPARATIVE RANDOMIZED CLINICAL TRIAL OF A MASTER-SLAVE INTERVENTIONAL ROBOT FOR PERCUTANEOUS LUNG PUNCTURE

杨雪玲  13:30-13:38

天津医科大学肿瘤医院[论文发言]

Dissecting the Immunological Network of HCC Post-Transarterial Chemoembolization Using Single-Cell RNA Sequencing

张聪  13:40-13:48

丽水市中心医院[论文发言]

Transarterial chemoembolization plus camrelizumab and rivoceranib for BCLC stage C hepatocellular carcinoma

周文杰  13:50-13:58

苏北人民医院[论文发言]

Modification of Endovascular Treatment Effects by White Matter Lesions in Patients with Large Ischemic Core: A Post-hoc Analysis of the ANGEL-ASPECT Trail

王赞  14:00-14:08

首都医科大学附属北京天坛医院[论文发言]

Precision brachytherapy combined with the VEGF-targeted inhibitor for high-grade glioma: clinical effect and mechanism verification

田川  14:10-14:18

青岛大学附属医院西海岸院区[论文发言]

Novel Occlusion-Reopen Technique For Perigraft Seroma In Arteriovenous Grafts: A Multicenter Report Of Five Cases

陈凌  14:20-14:28

重庆医科大学附属第一医院[论文发言]

TACE初始治疗HCC患者血清学炎症指标与预后的关系研究

赵卫  14:30-14:38

昆明医科大学第一附属医院[论文发言]